Richard J Bastin

Title: Richard J Bastin: Innovator in Pharmaceutical Formulations

Introduction

Richard J Bastin is a notable inventor based in Waterford, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HDAC inhibitors. With a total of 3 patents to his name, Bastin's work is focused on innovative solutions for treating various medical conditions.

Latest Patents

Bastin's latest patents revolve around pharmaceutical formulations of HDAC inhibitors. These inventions pertain to pharmaceutical compositions that include specific carbamic acid compounds, which inhibit histone deacetylase (HDAC) activity. For instance, one of his notable inventions includes PXD-101, N hydroxyl-3-(3-phenylsulfamoyl-phenyl)-acrylamide, combined with additional ingredients such as cyclodextrin, arginine, and meglumine. The applications of these compositions are significant, as they can be used in the inhibition of HDAC and in the treatment of conditions mediated by HDAC, including cancer, proliferative conditions, and psoriasis.

Career Highlights

Richard J Bastin is associated with Topotarget UK Limited, where he continues to advance his research and development efforts. His work has been instrumental in pushing the boundaries of pharmaceutical science, particularly in the area of cancer treatment.

Collaborations

Bastin collaborates with Nicholas J Hughes, contributing to the innovative research environment at Topotarget UK Limited. Their combined expertise enhances the potential for groundbreaking advancements in pharmaceutical formulations.

Conclusion

Richard J Bastin's contributions to the field of pharmaceuticals, particularly through his patents on HDAC inhibitors, highlight his role as a key innovator. His work not only advances scientific knowledge but also holds promise for improving treatment options for various medical conditions.